In addition, not only STAT3 but also the NOTCH1 signaling pathway is known to be involved in the acquisition of chemotherapy resistance in head and neck squamous cell carcinoma (HNSCC), breast cancer, and gastrointestinal cancer [21,22,23]. This evidence concerns the gene STAT3 and breast carcinoma.